Randomized controlled trial validates PlyoPulse EMS technology for aesthetic outcomes.
Sofwave has published data from a randomized controlled trial of its Pure Impact VIP platform using PlyoPulse EMS technology in the Aesthetic Surgery Journal. The publication strengthens the clinical evidence base for the device and positions it as a differentiated offering in the crowded RF microneedling and energy-device market.
PlyoPulse is Sofwave's proprietary pulsed electromagnetic stimulation technology, designed to enhance collagen remodeling and skin tightening outcomes. RCT data—especially in a peer-reviewed journal—carries weight with practices evaluating device purchases and with patients comparing treatment options.
Sofwave's Pure Impact VIP shows efficacy in peer-reviewed RCT for skin tightening.
For device owners and practice managers, published RCT data is a sales tool and a clinical justification. If you're considering Sofwave or comparing it to competitors like InMode or Cutera, this publication is worth reviewing. It also signals Sofwave's commitment to clinical validation, a differentiator in a market where many vendors rely on case reports and anecdotal evidence.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
